MODY Is Prevalent in Later-Onset Diabetes and Has Potential for Targeted Therapy but Is Challenging to Identify.

Saved in:
Bibliographic Details
Title: MODY Is Prevalent in Later-Onset Diabetes and Has Potential for Targeted Therapy but Is Challenging to Identify.
Authors: Sharp LN; Institute of Biomedical and Clinical Sciences, University of Exeter, Exeter, U.K., Mirshahi UL; Department of Genomic Health, Geisinger, Danville, PA., Colclough K; Institute of Biomedical and Clinical Sciences, University of Exeter, Exeter, U.K.; Exeter Genomics Laboratory, Royal Devon University Healthcare NHS Foundation Trust, Exeter, U.K., Hall TS; Institute of Biomedical and Clinical Sciences, University of Exeter, Exeter, U.K., Haley JS; Department of Genomic Health, Geisinger, Danville, PA., Cannon SJ; Institute of Biomedical and Clinical Sciences, University of Exeter, Exeter, U.K., Laver TW; Institute of Biomedical and Clinical Sciences, University of Exeter, Exeter, U.K., Weedon MN; Institute of Biomedical and Clinical Sciences, University of Exeter, Exeter, U.K., Hattersley AT; Institute of Biomedical and Clinical Sciences, University of Exeter, Exeter, U.K., Carey DJ; Department of Genomic Health, Geisinger, Danville, PA., Patel KA; Institute of Biomedical and Clinical Sciences, University of Exeter, Exeter, U.K.
Source: Diabetes [Diabetes] 2026 Jan 20; Vol. 75 (2), pp. 361-368.
Publication Type: Journal Article
Journal Info: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model: Print Cited Medium: Internet ISSN: 1939-327X (Electronic) Linking ISSN: 00121797 NLM ISO Abbreviation: Diabetes Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1939-327X
DOI:10.2337/db25-0545